Microbix Biosystems Company Description

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.

Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Microbix Biosystems Inc.

Country	Canada
Founded	1988
Industry	Biotechnology
Sector	Healthcare
Employees	100
CEO	Cameron L. Groome

Contact Details

Address: 265 Watline Avenue Mississauga, ON L4Z 1P3 Canada
Phone	905 361 8910
Website	microbix.com

Stock Details

Ticker Symbol	MBX
Exchange	Toronto Stock Exchange
Fiscal Year	October - September
Reporting Currency	CAD
ISIN Number	CA59501P1045

Key Executives

Name	Position
Cameron L. Groome	President, Chief Executive Officer and Director
James S. Currie	Chief Financial Officer
Dr. Kenneth Hughes Ph.D.	Chief Operating Officer
Dr. Mark Luscher Ph.D.	Senior Vice President of Scientific Affairs
Philip Casselli	Senior Vice President of Sales, Business Development and Marketing
Christopher B. Lobb	Compliance Officer, General Counsel and Secretary